Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03007017 · ClinicalTrials.gov registry record · NA
Novel Strategies for Innovating Deceased Donor Procurement
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03007017: Completed NA study, sponsored by University of Maryland, Baltimore.
NCT03007017 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03007017, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Despite many efforts to increase the size of the donor pool, there is a large and growing disparity between the number of donor kidneys available for transplantation and the number of patients on the transplant waiting list. Increasing the quality of currently available donor kidneys would potentially improve the longevity of deceased donor kidney transplants by years, thus increasing the rate of transplantation patients on the kidney transplant waiting list. In addition, recipients of higher quality kidneys have shorter hospital stays and lower total hospital charges. By innovating the organ donation process, such that deceased donor kidneys are removed prior to the cessation of cardiac activity, rather than after, it may be possible to improve the quality of the kidney before transplantation, resulting in improved function after transplantation and increased longevity of these transplanted kidneys. Further, this improved kidney quality is highly likely to translate to reduced need for renal dialysis and other high-cost interventions, yielding lower total hospital charges. In this study we will test the hypothesis that, through a cost-free technical innovation, the quality of deceased donor kidneys could be improved significantly, saving thousands more lives per year and reducing total health care expenditures on renal transplantation.
Primary Outcome
Renal allograft survival
Interventions
- PROCEDURE Deceased donor nephrectomy, prior to cross clamp of donor aorta
- PROCEDURE Deceased donor nephrectomy, standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-01 |
| Est. Completion | 2021-06-07 |
| Phase | NA |
What the finished NCT03007017 record still lists
NCT03007017 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Deceased donor nephrectomy, prior to cross clamp of donor aorta is the first listed.
NCT03007017 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03007017 about?
NCT03007017 is a clinical study titled "Novel Strategies for Innovating Deceased Donor Procurement". Despite many efforts to increase the size of the donor pool, there is a large and growing disparity between the number of donor kidneys available for transplantation and the number of patients on the transplant waiting list. Increasing the quality of currently available donor kidneys would potential...
What is the current status of trial NCT03007017?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2017-01. Estimated completion is 2021-06-07.
What interventions are being tested in trial NCT03007017?
The interventions under investigation include: Deceased donor nephrectomy, prior to cross clamp of donor aorta (PROCEDURE), Deceased donor nephrectomy, standard of care (PROCEDURE).
Who is sponsoring clinical trial NCT03007017?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03007017's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia